CVS Health (NYSE: CVS) reported Q3 EPS of $2.09, $0.09 better than the analyst estimate of $2.00. Revenue for the quarter came in at $81.16 billion versus the consensus estimate of $76.76 billion.

GUIDANCE:

CVS Health sees FY2022 EPS of $8.55-$8.65, versus the consensus of $8.55.

For earnings history and earnings-related data on CVS Health (CVS) click here.